Mayo Clinic Study Offers Physicians Guidance on CBD

September 6, 2019 08:00:03

One of the biggest stumbling blocks to the wider use of CBD has been the reluctance of the mainstream medical professionals to embrace this form of treatment since they don’t have ample information about how CBD works. A study by Mayo Clinic sought to address this information gap and among other things, it made suggestions about how physicians can guide their patients to the best CBD products. We have the highlights of those recommendations.

Product Source

Doctors were advised to inform their patients that the lack of regulation at the federal level means that it is not as easy to ascertain the quality of the CBD product that one wishes to buy. However, there are exceptions for states like Colorado and Oregon which have very strict standards that CBD products must meet before they are allowed on the market. If the desired products aren’t available from these states with strict product standards, then patients can explore products from Europe since Europe has a well-developed regulatory system for CBD products.

Extraction Methods

The Mayo Clinic study also discovered that the best CBD products are those which were extracted using the carbon dioxide extraction method rather than those extracted using solvents. Solvents leave contaminants in the CBD, and this lowers product quality. Physicians should therefore advise patients to buy CBD products where the CO2 extraction method was used.

Organic Certification

Concerns about organophosphates and their effects on human health are serious, so one should only buy CBD products which are certified as organic by a reputable entity, such as the USDA. This will provide assurance that the CBD product doesn’t have any chemical contaminants that can compromise the very health that a patients is trying to enhance or improve.

THC Level

There is concern about the possibility of a CBD product user being unintentionally exposed to high levels of THC in poor-quality products. For this reason, the Mayo Clinic recommends that patients only buy CBD products with third-party quality tests that show that the THC content of those products is less than 0.3 percent. Products from Europe conform to an even stricter THC limit of 0.2 percent, so one can explore those as well.

Know Hempseed Oil and Its Limitations

Hempseed oil is extracted from hemp seeds, and these are low in cannabinoids. Physicians were therefore advised to guide their patients so that those patients buy CBD oil products since these have the cannabinoid which has undergone research that has pointed to its efficacy in treating different conditions, such as pain, nausea and anxiety.

All in all, the Mayo Clinic review provides valuable insights for healthcare professionals, and CBD industry experts agree that industry players like Marijuana Company of America Inc. (OTCQB: MCOAD) and Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) will applaud since it provides further proof that CBD products have medicinal value.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office